
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [NVO] Novo Nordisk
Data updated 2025-Apr-23 (Wednesday)Compare current performance/technical metrics to history for Novo Nordisk. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2025-Apr-23 Wednesday
Day Change | +2.30% Top | Day Volatility | 2.53% Top |
Streak | ↑ 3 days Top | % Streak | +5.53% Top |
RSI | 38 Low | CCI | -64.1 Low |
MACD | 0.12 Mid | ATR | 3.05 Mid |
ADX | 40.2 Top | SSO | 18.0 Low |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | -4.96% Low | 13.00% Top | +1.98% Top |
10-day | -0.50% Mid | 17.11% Top | -1.47% Low |
20-day | -16.73% Low | 27.82% Top | -5.26% Low |
50-day | -26.96% Low | 64.56% Top | -18.87% Low |
100-day | -41.38% Low | 97.40% Top | -27.17% Low |
200-day | -56.95% Low | 152.09% Mid | -41.22% Low |
Choose Metric type
Choose from Technical Indicators above to analyze
Novo Nordisk had a Relative Strength Index (RSI) of 37.98 on 2025-Apr-23; See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2025-Apr-23 value annotated for comparison. Technical indicators calculated using daily values (For details check here)
Related to Novo Nordisk
Information for Novo Nordisk
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-23 on Google
SEC Reports : Quarterly reports around 2025-Apr-23 on SEC Edgar
Compare Novo Nordisk with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Novo Nordisk
Industry : Pharmaceuticals industry performance which includes Novo Nordisk